News
Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.
Apellis Pharmaceuticals focuses on creating medicines targeting eye diseases and rare neurological diseases. Read why I rate ...
In an effort to become more nimble, some companies, like Bayer Pharmaceutical, are getting rid of middle managers.
Mankind Pharma’s Q4 profit declined 10.7% even as revenue grew 27% YoY. Management cited BSV integration, chronic therapy ...
Sun Pharmaceutical Industries Ltd. closed 11.66% short of its 52-week high of 1,960.20 rupees, which the company reached on ...
Lilly—a manufacturer of medicines like Mounjaro, Zepbound and Ebglyss—is considering purchasing 236 acres from Generation ...
A new report from Impiricus and CMI finds that HCPs are looking for pharma to provide more educational support about clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback